Since ACC is also characterized by an overexpression of the insulin-like growth factor 1 receptor (IGF1-R), anti-IGF1-R immunoliposomes have been described as an effective approach for enhancing cellular uptake and should therefore be investigated in future studies for improving the formulation of DOPC-MT [48,49]. This evidence concerns the gene IGF1R and adrenal cortex carcinoma.